Exosomes as carriers of Alzheimer's amyloid-ß

Frontiers in Neuroscience

Volumn 11, Issue APR, 2017, Pages

  Yuyama, Kohei ^a   Igarashi, Yasuyuki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Amyloid ; Exosome; Glycosphingolipid; Microglia

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; EXOSOME; HUMAN; MICROGLIA; NONHUMAN; PATHOGENESIS; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN TRANSPORT;

EID: 85019046729     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2017.00229     Document Type: Article

References (41)

1. Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., and Wood, M. J. (2011). Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29, 341-345. doi: 10.1038/nbt.1807
2. An, K., Klyubin, I., Kim, Y., Jung, J. H., Mably, A. J., O'Dowd, S. T., et al. (2013). Exosomes neutralize synaptic-plasticity-disrupting activity of Aß assemblies in vivo. Mol. Brain 6:47. doi: 10.1186/1756-6606-6-47
3. Ansari, S. A., Satar, R., Perveen, A., and Ashraf, G. M. (2017). Current opinion in Alzheimer's disease therapy by nanotechnology-based approaches. Curr. Opin. Psychiatry 30, 128-135. doi: 10.1097/YCO.0000000000000310
4. Ariga, T., McDonald, M. P., and Yu, R. K. (2008). Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease-a review. J. Lipid Res. 49, 1157-1175. doi: 10.1194/jlr.R800007-JLR200
5. Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Hayder, T., et al. (2015). Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci. 18, 1584-1593. doi: 10.1038/nn.4132
6. Ashraf, G. M., Greig, N. H., Khan, T. A., Hassan, I., Tabrez, S., Shakil, S., et al. (2014). Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus. CNS Neurol. Disord. Drug Targets 13, 1280-1293. doi: 10.2174/1871527313666140917095514
7. Ashraf, G. M., Tabrez, S., Jabir, N. R., Firoz, C. K., Ahmad, S., Hassan, I., et al. (2015). An overview on global trends in nanotechnological approaches for alzheimer therapy. Curr. Drug Metab. 16, 719-727. doi: 10.2174/138920021608151107125757
8. Bakhti, M., Winter, C., and Simons, M. (2011). Inhibition of myelin membrane sheath formation by oligodendrocyte-derived exosome-like vesicles. J. Biol. Chem. 286, 787-796. doi: 10.1074/jbc.M110.190009
9. Bulloj, A., Leal, M. C., Xu, H., Castaño, E. M., and Morelli, L. (2010). Insulin-degrading enzyme sorting in exosomes: a secretory pathway for a key brain amyloid-ß degrading protease. J. Alzheimer's Dis. 19, 79-95. doi: 10.3233/JAD-2010-1206
10. Cataldo, A. M., Barnett, J. L., Pieroni, C., and Nixon, R. A. (1997). Increased neuronal endocytosis and protease delivery to early endosomes in sporadic alzheimer's disease: neuropathologic evidence for a mechanism of increased ß-amyloidogenesis. J. Neurosci. 17, 6142-6151
11. Cataldo, A. M., Petanceska, S., Terio, N. B., Peterhoff, C. M., Durham, R., Mercken, M., et al. (2004). Aß localization in abnormal endosomes: association with earliest Aß elevations in AD and down syndrome. Neurobiol. Aging 25, 1263-1272. doi: 10.1016/j.neurobiolaging.2004.02.027
12. Cataldo, A., Rebeck, G. W., Ghetri, B., Hulette, C., Lippa, C., Van Broeckhoven, C., et al. (2001). Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders. Ann. Neurol. 50, 661-665
13. Danish Rizvi, S. M., Shaikh, S., Waseem, S. M., Shakil, S., Abuzenadah, A. M., Biswas, D., et al. (2015). Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease. EXCLI J. 14, 684-696. doi: 10.17179/excli2015-252
14. Dinkins, M. B., Enasko, J., Hernandez, C., Wang, G., Kong, J., Helwa, I., et al. (2016). Neutral sphingomyelinase-2 deficiency ameliorates Alzheimer's disease pathology and improves cognition in the 5XFAD Mouse. J. Neurosci. 36, 8653-8667. doi: 10.1523/JNEUROSCI.1429-16.2016
15. Fiandaca, M. S., Kapogiannis, D., Mapstone, M., Boxer, A., Eitan, E., Schwartz, J. B., et al. (2015). Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement. 11, 600-607. doi: 10.1016/j.jalz.2014.06.008
16. Fitzner, D., Schnaars, M., van Rossum, D., Krishnamoorthy, G., Dibaj, P., Bakhti, M., et al. (2011). Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J. Cell Sci. 124, 447-458. doi: 10.1242/jcs.074088
17. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi: 10.1126/science.1072994
18. Hong, S., Ostaszewski, B. L., Yang, T., O'Malley, T. T., Jin, M., Yanagisawa, K., et al. (2014). Soluble Aß oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes. Neuron 82, 308-319. doi: 10.1016/j.neuron.2014.02.027
19. Howitt, J., and Hill, A. F. (2016). Exosomes in the pathology of neurodegenerative diseases. J. Biol. Chem. 291, 26589-26597. doi: 10.1074/jbc.R116.757955
20. Katsuda, T., Tsuchiya, R., Kosaka, N., Yoshioka, Y., Takagaki, K., Oki, K., et al. (2013). Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci. Rep. 3:1197. doi: 10.1038/srep01197
21. Langui, D., Girardot, N., El Hachimi, K. H., Allinquant, B., Blanchard, V., Pradier, L., et al. (2010). Subcellular topography of neuronal Aß peptide in APPxPS1 transgenic mice. Am. J. Pathol. 165, 1465-1477. doi: 10.1016/S0002-9440(10)63405-0
22. Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009). Cellular prion protein mediates impairment of synaptic plasticity by amyloid-ß oligomers. Nature 457, 1128-1132. doi: 10.1038/nature07761
23. Lopez-Verrilli, M. A., Picou, F., and Court, F. A. (2013). Schwann cell-derived exosomes enhance axonal regeneration in the peripheral nervous system. Glia 61, 1795-1806. doi: 10.1002/glia.22558
24. Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., et al. (2010). Decreased clearance of CNS ß-Amyloid in Alzheimer's disease. Science 330:1774. doi: 10.1126/science.1197623
25. Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T., and Nagata, S. (2007). Identification of Tim4 as a phosphatidylserine receptor. Nature 450, 435-439. doi: 10.1038/nature06307
26. Perez-Gonzalez, R., Gauthier, S. A., Kumar, A., and Levy, E. (2012). The exosome secretory pathway transports amyloid precursor protein carboxyl-terminal fragments from the cell into the brain extracellular space. J. Biol. Chem. 287, 43108-43115. doi: 10.1074/jbc.M112.404467
27. Rajendran, L., and Annaert, W. (2012). Membrane trafficking pathways in Alzheimer's disease. Traffic 13, 759-770. doi: 10.1111/j.1600-0854.2012.01332.x
28. Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., et al. (2006). Alzheimer's disease ß-Amyloid peptides are released in association with exosomes. Proc. Natl. Acad. Sci. U.S.A. 103, 11172-11177. doi: 10.1073/pnas.0603838103
29. Sato, Y. T., Umezaki, K., Sawada, S., Mukai, S. A., Sasaki, Y., Harada, N., et al. (2016). Engineering hybrid exosomes by membrane fusion with liposomes. Sci. Rep. 6:21933. doi: 10.1038/srep21933
30. Schlegel, R. A., and Williamson, P. (2001). Phosphatidylserine, a death knell. Cell Death Differ. 8, 551-563. doi: 10.1038/sj.cdd.4400817
31. Sharples, R. A., Vella, L. J., Nisbet, R. M., Naylor, R., Perez, K., Barnham, K. J., et al. (2008). Inhibition of ?-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes. FASEB J. 22, 1469-1478. doi: 10.1096/fj.07-9357com
32. Takahashi, R. H., Milner, T. A., Li, F., Nam, E. E., Edgar, M. A., Yamaguchi, H., et al. (2002). Intraneuronal Alzheimer Aß42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161, 1869-1879. doi: 10.1016/S0002-9440(10)64463-X
33. Vingtdeux, V., Hamdane, M., Loyens, A., Gelé, P., Drobeck, H., Bégard, S., et al. (2007). Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. J. Biol. Chem. 282, 18197-18205. doi: 10.1074/jbc.M609475200
34. Xiao, T., Zhang, W., Jiao, B., Pan, C. Z., Liu, X., and Shen, L. (2017). The role of exosomes in the pathogenesis of Alzheimer' disease. Transl. Neurodegener. 6:3. doi: 10.1186/s40035-017-0072-x
35. Yamamoto, N., Matsubara, T., Sato, T., and Yanagisawa, K. (2008). Age-dependent high-density clustering of gm1 ganglioside at presynaptic neuritic terminals promotes amyloid ß-protein fibrillogenesis. Biochim. Biophys. Acta 1778, 2717-2726. doi: 10.1016/j.bbamem.2008.07.028
36. Yanagisawa, K., Odaka, A., Suzuki, N., and Ihara, Y. (1995). GM1 ganglioside-bound amyloid beta-protein (a Beta): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 1, 1062-1066
37. Yuyama, K., and Igarashi, Y. (2016). Physiological and pathological roles of exosomes in the nervous system. Biomol. Concepts 7, 53-68. doi: 10.1515/bmc-2015-0033
38. Yuyama, K., Sun, H., Mitsutake, S., and Igarashi, Y. (2012). Sphingolipid-modulated exosome secretion promotes clearance of amyloid-ß by microglia. J. Biol. Chem. 287, 10977-10989. doi: 10.1074/jbc.M111.324616
39. Yuyama, K., Sun, H., Sakai, S., Mitsutake, S., Okada, M., Hidetoshi, T., et al. (2014). Decreased Amyloid-ß pathologies by intracerebral loading of glycosphingolipid-enriched exosomes in Alzheimer model mice. J. Biol. Chem. 289, 24488-24498. doi: 10.1074/jbc.M114.577213
40. Yuyama, K., Sun, H., Usuki, S., Sakai, S., Hanamatsu, H., Mioka, T., et al. (2015). A Potential function for neuronal exosomes: sequestering intracerebral amyloid-ß peptide. FEBS Lett. 589, 84-88. doi: 10.1016/j.febslet.2014.11.027
41. Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R. C., et al. (2011). Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther. 19, 1769-1779. doi: 10.1038/mt.2011.164